Abdominal Chemodectomas with Cutaneous Angiolipomas
What is Abdominal Chemodectomas with Cutaneous Angiolipomas?
Abdominal Chemodectomas with Cutaneous Angiolipomas is a rare inherited medical condition that causes tumors to grow in the abdomen of patients.What are the symptoms of Abdominal Chemodectomas with Cutaneous Angiolipomas?
Patients diagnosed with Abdominal Chemodectomas with Cutaneous Angiolipomas may have symptoms that include:- Abdominal pain
- Abdominal swelling
- Intestinal obstruction
- Leg swelling
- Abdominal discomfort
What causes Abdominal Chemodectomas with Cutaneous Angiolipomas?
Abdominal Chemodectomas with Cutaneous Angiolipomas is inherited in an autosomal dominant manner. According to Medline Plus, autosomal dominant inheritance means that the patient has inherited the disease from one family member, who most likely has the same disease. A parent with Abdominal Chemodectomas with Cutaneous Angiolipomas has a 50% chance of passing it to their offspring.How is Abdominal Chemodectomas with Cutaneous Angiolipomas diagnosed?
Abdominal Chemodectomas with Cutaneous Angiolipomas is diagnosed with the discovery of a tumor in the lymphatic tissues of the abdomen.What are the treatments for Abdominal Chemodectomas with Cutaneous Angiolipomas?
Currently, no treatments for Abdominal Chemodectomas with Cutaneous Angiolipomas are available.Where can I find out more about Abdominal Chemodectomas with Cutaneous Angiolipomas?
Abdominal Chemodectomas with Cutaneous Angiolipomas Articles

Real-World Evidence Sheds Light on SYMPAZAN® Oral Film Use for Lennox-Gastaut Syndrome
Bree Clare
September 21, 2025
Read More »


aTyr Pharma Shares Plummet After Lead Drug Fails in Key Lung Disease Trial
Bree Clare
September 20, 2025
Read More »

Microbial Allies: How Bacteria Are Revolutionizing Cancer Treatment
Bree Clare
September 19, 2025
Read More »

Exercise and Colon Cancer: Can Exercise Reprogram Genes? And Help Colon Cancer Survivors?
Bree Clare
September 19, 2025
Read More »

Simple Combined Test Offers New Hope for Improved Outcomes in Gastric Cancer
Bree Clare
September 19, 2025
Read More »


Dewpoint Therapeutics Secures Series D Funding to Pioneer Novel Gastric Cancer Therapy
Bree Clare
September 18, 2025
Read More »